SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MANSERVIGI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.300
AS - Asia 5.138
EU - Europa 2.866
SA - Sud America 817
AF - Africa 108
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 5
Totale 19.247
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.104
SG - Singapore 1.841
CN - Cina 1.458
BR - Brasile 623
UA - Ucraina 606
VN - Vietnam 540
GB - Regno Unito 432
DE - Germania 424
HK - Hong Kong 402
TR - Turchia 348
IT - Italia 343
FR - Francia 200
PL - Polonia 183
FI - Finlandia 177
SE - Svezia 161
RU - Federazione Russa 128
BD - Bangladesh 118
JP - Giappone 106
CA - Canada 90
IN - India 90
MX - Messico 75
AR - Argentina 71
ZA - Sudafrica 52
IQ - Iraq 48
NL - Olanda 46
BE - Belgio 40
AT - Austria 36
EC - Ecuador 32
CO - Colombia 30
ID - Indonesia 28
ES - Italia 27
PK - Pakistan 23
VE - Venezuela 22
UZ - Uzbekistan 16
LT - Lituania 15
IR - Iran 14
CL - Cile 13
MA - Marocco 13
PH - Filippine 13
SA - Arabia Saudita 13
MY - Malesia 12
PY - Paraguay 11
KR - Corea 9
AE - Emirati Arabi Uniti 8
CZ - Repubblica Ceca 8
AU - Australia 7
CR - Costa Rica 7
EG - Egitto 7
IL - Israele 7
JM - Giamaica 7
KE - Kenya 7
TN - Tunisia 7
NZ - Nuova Zelanda 6
PE - Perù 6
UY - Uruguay 6
BY - Bielorussia 5
LB - Libano 5
NP - Nepal 5
OM - Oman 5
CH - Svizzera 4
HN - Honduras 4
JO - Giordania 4
RO - Romania 4
RS - Serbia 4
SN - Senegal 4
AO - Angola 3
AZ - Azerbaigian 3
BH - Bahrain 3
BO - Bolivia 3
DK - Danimarca 3
DZ - Algeria 3
ET - Etiopia 3
EU - Europa 3
MZ - Mozambico 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AL - Albania 2
BG - Bulgaria 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GR - Grecia 2
HR - Croazia 2
KW - Kuwait 2
KZ - Kazakistan 2
LI - Liechtenstein 2
MD - Moldavia 2
MN - Mongolia 2
NO - Norvegia 2
TH - Thailandia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
EE - Estonia 1
GD - Grenada 1
GT - Guatemala 1
IE - Irlanda 1
Totale 19.234
Salva come PNG Salva come JPEG
Città #
Singapore 1.228
Ashburn 1.096
Woodbridge 891
Fairfield 841
San Jose 648
Jacksonville 619
Houston 609
Chandler 504
Beijing 459
Ann Arbor 458
Santa Clara 416
Hong Kong 396
Seattle 337
Wilmington 331
Cambridge 283
New York 252
Nanjing 194
Izmir 188
Warsaw 172
Los Angeles 164
Ho Chi Minh City 152
Hanoi 144
Dallas 134
Princeton 134
Tokyo 100
Lauterbourg 97
San Diego 87
Buffalo 82
Munich 78
São Paulo 65
Boardman 63
Milan 62
Shanghai 58
Shenyang 58
Orem 54
Tianjin 52
Mexico City 51
Helsinki 48
Nanchang 47
Brussels 39
Hefei 39
Chicago 38
Hebei 38
Frankfurt am Main 37
Jiaxing 37
The Dalles 37
San Mateo 34
Ferrara 32
Toronto 30
Vienna 30
Brooklyn 29
Da Nang 28
London 28
Montreal 28
Changsha 27
Chennai 26
Council Bluffs 24
Jinan 24
Johannesburg 23
Ningbo 23
San Francisco 23
Washington 22
Baghdad 21
Philadelphia 21
Denver 20
Guangzhou 20
Norwalk 20
Poplar 20
Stockholm 20
Falls Church 19
Moscow 19
Rio de Janeiro 19
Boston 18
Mountain View 17
Turku 17
Ankara 16
Hải Dương 16
Amsterdam 15
Augusta 15
Dearborn 15
Kunming 15
Leawood 15
Manchester 15
Auburn Hills 14
Haiphong 14
Phoenix 14
Atlanta 13
Medellín 13
Rome 13
Tashkent 13
Belo Horizonte 12
Biên Hòa 12
Bologna 12
Falkenstein 12
Mumbai 12
Orange 12
Verona 12
Zhengzhou 12
Caracas 11
Curitiba 11
Totale 12.933
Salva come PNG Salva come JPEG
Nome #
Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors 327
Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer 274
Antitumor effects of non-replicative herpes simplex vectors expressing antiangiogenic proteins and thymidine kinase on Lewis lung carcinoma establishment and growth. 269
Analysis of HSV isolated from patients with unilateral and bilateral herpetic keratitis 263
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 262
A BK virus episomal vector for constitutive high expression of exogenous cDNAs in human cells 251
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 244
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 243
Characterization of a herpes simplex virus type 1 mutant resistant to benzhydrazone, a selective inhibitor of herpesvirus glycosylation 242
Herpetic vectors inhibiting angiogenesis and inducing cell suicide in gliomas 237
Characterization of herpes simplex virus type 1 recombinants that express and incorporate high levels of HCV E2-gC chimeric proteins 232
A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease 226
Herpesvirus-based vectors for gene transfer, gene therapy and the development of novel vaccines 225
A herpes simplex virus type 1 mutant resistant to benzhydrazone, an inhibitor of glycoprotein synthesis in herpesvirus-infected cells. Preliminary mapping of benzhydrazone-resistance and of a novel syncitial mutation 221
HSV as a vector in vaccine development and gene therapy 216
A Lentiviral Vector-Based, Herpes Simplex Virus 1 (HSV-1) Glycoprotein B Vaccine Affords Cross-Protection against HSV-1 and HSV-2 Genital Infections 216
Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model 206
Characterization of virus obtained from MDBK cells persistently infected with a variant of herpes simplex virus type 1 strain MP [HSV-1(MP)] 205
Herpesvirus-based vaccines 204
Membrane protein pattern in hereditary spherocytosis in five subjects from north-east Italy obtained by SDS-PAGE using N,N'-diallyltartardiamide 200
HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy 200
An S/MAR-based infectious episomal genomic DNA expression vector provides long-term regulated functional complementation of LDLR deficiency. 199
Replication-competent herpes simplex vectors: design and applications 198
Cationic liposomes as carriers for ocular administration of anti herpetic peptides 196
Mice genetic immunization with plasmid DNA encoding a secreted form of HSV-1 gB induces a protective immune response against herpes simplex virus type 1 infection 195
Capitolo 55 Retrovirus 193
Expression of herpes simplex virus 1 glycoprotein B in human cells and protection of mice against lethal herpes simplex virus 1 infection 192
HSV as a vector in vaccine development and gene therapy 192
High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B 187
Herpes Simplex Virus Growth, Preparation, and Assay 186
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 185
Protection from bacterial infection by a single vaccination with replication-deficient mutant herpes simplex virus type 1 183
Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide 181
Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread 181
null 179
Purinergic Signaling: A New Pharmacological Target Against Viruses? 177
Herpes Simplex Virus Type 1 (HSV-1) Uracil-DNA Glycosylase: Functional Expression in Escherichia coli, Biochemical Characterization, and Selective Inhibition by 6-(p-n-Octylanilino)Uracil 175
Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: Immunogenicity and protection in mice 175
Cationic liposomes carrying anti herpetic peptides as potential ocular vaccine 174
Role of Herpes Simplex Envelope Glycoprotein B and Toll-Like Receptor 2 in Ocular Inflammation: An ex vivo Organotypic Rabbit Corneal Model 173
Comunicazione orale, KN: A New Vaccine Approach To Fight Mycobacterium Tuberculosis 168
Poster: Herpes simplex vaccine vector co-expressing fused Mycobacterium Tuberculosis immunogens and Tat adjuvant enhances cellular and humoral responses in Balb/c mice 168
The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells 167
Viral Vector Expressing Tat As Immunomodulatory Molecule Represent A New Vaccine Strategy Against HSV Infection 167
Intra-tissue characteristics of chloroplasts in the lamina and petiole of mature winter leaf of Arum italicum Miller 166
Cell-type dependent sensitivity of herpes simplex virus 1 mutants to plaque development inhibition by an anti-gD monoclonal antibody. 166
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 166
In vitro antiviral activity of Emblica officinalis extracts and GC/MS identified compounds 165
IMMUNIZZAZIONE PASSIVA CON SIERO POLICLONALE NELLA CHERATITE ERPETICA SPERIMENTALE 163
Effects of the passive transfer of anti-gB antibodies in a rabbit model of HSV-1-induced keratitis 163
Phenotypic and genotypic characterization of locus Syn 5 in Herpes simplex virus 1. 162
Osservazioni cliniche e microbiologiche su un campione di donne controllate ambulatoriamente 162
Comparative analysis of the virion polypeptides specified by Herpes simplex virus type 2 strains 160
EVIDENCE FOR GLYCOPROTEIN ABNORMALITY IN PLATELETS FROM PATIENTS WITH MAY-HEGGLIN ANOMALY 160
Synthesis and anti-HSV-1 activity of 6 substituted pyrazolo[3,4-d]pyridazin-7-one nucleosides 158
Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide 157
Local and systemic inoculation of DNA or protein gB1s-based vaccines induce a protective immunity against rabbit ocular HSV-1 infection 156
Identification of replication-competent HSV-1 Cgal(+) strain targets in a mouse model of human hepatocarcinoma xenograft 156
Capitolo 44 Herpesviridae 154
State of viral DNA in BK virus-transformed rabbit cells 154
Herpesvirus/retrovirus chimeric vectors 152
Expression of the herpes simplex virus type 1 glycoprotein E in human cells and in Escherichia coli: Protection studies against lethal viral infection in mice 151
HERPES-SIMPLEX VIRUS TYPE-1 URACIL-DNA GLYCOSYLASE - CLONING AND CHARACTERIZATION 150
Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model 150
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 147
Expression of hepatitis C virus envelope glycoproteins by herpes simplex virus type 1-based amplicon vectors 146
The C-terminal cytoplasmic tail of herpes simplex virus type 1 gE protein is phosphorylated in vivo and in vitro by cellular enzymes in the absence of other viral proteins 146
Eudragit microparticles as a possible tool for ophthalmic administration of acyclovir 143
In vitro antiviral activity of Emblica officinalis extracts and GC/MS identified compounds 143
Replication-deficient mutant Herpes Simplex Virus-1 targets professional antigen presenting cells and induces efficient CD4+ T helper responses 142
Effetto sterilizzante dell'acido peracetico su siero da impiegarsi per la coltivazione in vitro delle cellule animali. 141
HSV Recombinant Vectors for Gene Therapy 140
Replication-competent herpes simplex virus type 1 mutant expressing an autofluorescent glycoprotein H fusion protein 139
HSV-1 virions engineered for specific binding to cell surface receptors 135
Experimental keratitis in rabbits by human HSV-1 variants: prevention andtreatment 135
Immunotherapeutic activity of a recombinant glycoprotein vaccine aganst recurrent genital herpes in a guinea pig model. 131
Gene transfer into neurones for the molecular analysis of behaviour: focus on herpes simplex vectors 130
Temperature-sensitive mutants of HSV-1: Complementation and partial characterization 125
Transformation by defined regions of herpes simplex virus DNA. 124
Plaque dissociation of herpes sinplex viruses: biochemical and biological characters of the viral variants 123
Molecular diagnosis of herpes simplex encephalitis 122
Inhibition of human immunodeficiency virus reactivation from latency by tat antisense RNA and a tat transdominant negative mutant 122
APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells 122
Expression of human immunodeficiency virus type 1 tat from a replication-deficient herpes simplex type 1 vector induces antigen-specific T cell responses 120
Gene therapy of the nervous system by herpes virus vectors 119
Vettori erpetici per la terapia genica di patologie del sistema nervoso centrale. 118
Niosomes for vaginal administration of an antiherpetic peptide 118
Ocular disease patterns caused by genetically related mutants of herpes simplex virus type I 116
Use of replication deficient hsv-1 as a vaccine vector for the deli vary of hiv-1 tat antigen 114
Espressione in cellule umane del gene della glicoproteina B del virus dell'herpes simplex inserito in un vettore eucariotico 111
Protective immunity against genital herpes in mice obtained by non-ionic surfactant vesiclescontaining a secreted recombinant form of gB protein 111
Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA 111
Escherichia coli expressed herpes simplex virus gG1 and gG2 proteins in ELISA and immunoblotting assays 110
Liposomes carrying anti herpetic peptides as a tool for a potential ocular vaccine 110
Niosomes containing HSV immunogens as possible vaccine against genital herpes 109
null 107
Constitutive expression in human cells of herpes simplex type 1 glycoprotein B gene cloned in an episomal eukaryotic vector 106
HIV-1 matrix protein p17 modulates in vivo preactivated murine T-cell response and enhances the induction of systemic and mucosal immunity against intranasally co-administered antigens 106
null 104
Virus vectors for immunoprophylaxis 104
Totale 16.775
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.335
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.492
Totale 86.827
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202175 0 0 0 0 0 0 0 0 0 0 0 75
2021/20221.407 58 137 86 83 76 48 70 65 56 91 124 513
2022/20231.152 131 48 64 149 176 186 42 106 143 10 68 29
2023/2024672 68 78 29 24 60 180 38 39 15 7 7 127
2024/20252.197 59 48 186 88 280 249 51 97 270 257 332 280
2025/20267.065 755 273 643 959 1.054 496 761 357 666 751 312 38
Totale 19.341